{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:13:17Z","timestamp":1722453197790},"reference-count":39,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/mmr.2016.5989","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T09:12:31Z","timestamp":1481015551000},"page":"263-270","source":"Crossref","is-referenced-by-count":6,"title":["Down syndrome critical region 1 positively correlates with angiogenesis in hypopharyngeal cancer"],"prefix":"10.3892","volume":"15","author":[{"given":"Chao","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,12,6]]},"reference":[{"key":"key20180108015749_b1-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/lary.24915","article-title":"Survival trends in Hypopharyngeal cancer: A population-based review","volume":"125","author":"Newman","year":"2015","journal-title":"Laryngoscope"},{"key":"key20180108015749_b2-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/S0959-8049(98)00328-1","article-title":"Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE working group","volume":"34","author":"Berrino","year":"1998","journal-title":"Eur J Cancer"},{"key":"key20180108015749_b3-mmr-15-01-0263","first-page":"2481","article-title":"Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells","volume":"23","author":"Li","year":"2003","journal-title":"Anticancer Res"},{"key":"key20180108015749_b4-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"key":"key20180108015749_b5-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"key20180108015749_b6-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180108015749_b7-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"key20180108015749_b8-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjc.6603487","article-title":"The role of the VEGF-C\/VEGFR-3 axis in cancer progression","volume":"96","author":"Su","year":"2007","journal-title":"Br J Cancer"},{"key":"key20180108015749_b9-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/84579","article-title":"From angiogenesis to lymphangiogenesis","volume":"7","author":"Plate","year":"2001","journal-title":"Nat Med"},{"key":"key20180108015749_b10-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180108015749_b11-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/hmg\/9.11.1681","article-title":"DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways","volume":"9","author":"Fuentes","year":"2000","journal-title":"Hum Mol Genet"},{"key":"key20180108015749_b12-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00018-005-5085-4","article-title":"Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease","volume":"62","author":"Harris","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"key20180108015749_b13-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood-2004-01-0273","article-title":"Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells","volume":"104","author":"Hesser","year":"2004","journal-title":"Blood"},{"key":"key20180108015749_b14-mmr-15-01-0263","first-page":"103","article-title":"Frequency of cardiovascular and gastrointestinal malformations, leukemia and hypothyroidism in children with Down syndrome in Trabzon, Turkey","volume":"40","author":"Aynaci","year":"1998","journal-title":"Turk J Pediatr"},{"key":"key20180108015749_b15-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.1074\/jbc.275.12.8719","article-title":"A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling","volume":"275","author":"Rothermel","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180108015749_b16-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.0237225100","article-title":"Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy","volume":"100","author":"Vega","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108015749_b17-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000079832","article-title":"Down syndrome candidate region 1, a downstream target of VEGF, participates in endothelial cell migration and angiogenesis","volume":"41","author":"Iizuka","year":"2004","journal-title":"J Vasc Res"},{"key":"key20180108015749_b18-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbrc.2004.06.176","article-title":"VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: A mechanism for feedback regulation of angiogenesis?","volume":"321","author":"Yao","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108015749_b19-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1442-2042.2005.01174.x","article-title":"Testicular tumor in Down syndrome","volume":"12","author":"Suzuki","year":"2005","journal-title":"Int J Urol"},{"key":"key20180108015749_b20-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.0.CO;2-M","article-title":"A tumor profile in Down syndrome","volume":"78","author":"Satg\u00e9","year":"1998","journal-title":"Am J Med Genet"},{"key":"key20180108015749_b21-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ijc.21518","article-title":"Cancer incidence of persons with Down syndrome in Finland: A population-based study","volume":"118","author":"Patja","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180108015749_b22-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nature08062","article-title":"Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1","volume":"459","author":"Baek","year":"2009","journal-title":"Nature"},{"key":"key20180108015749_b23-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature06446","article-title":"Trisomy represses Apc (Min)-mediated tumours in mouse models of Down's syndrome","volume":"451","author":"Sussan","year":"2008","journal-title":"Nature"},{"key":"key20180108015749_b24-mmr-15-01-0263","first-page":"848","article-title":"Study of expression and significance of DSCR1 gene in laryngopharynx cancer and peri-cancerous tissues","volume":"25","author":"Lu","year":"2011","journal-title":"Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"key20180108015749_b25-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/01.ATV.0000098644.03153.6F","article-title":"Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1 and Nor1","volume":"23","author":"Liu","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180108015749_b26-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1016018617152","article-title":"CDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells","volume":"4","author":"Abe","year":"2001","journal-title":"Angiogenesis"},{"key":"key20180108015749_b27-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"key20180108015749_b28-mmr-15-01-0263","first-page":"138","volume-title":"UICC TNM classification of malignant tumours","author":"Sobin","year":"1997","edition":"5th"},{"key":"key20180108015749_b29-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ccr.2008.02.018","article-title":"Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth","volume":"13","author":"Ryeom","year":"2008","journal-title":"Cancer Cell"},{"key":"key20180108015749_b30-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0002-9440(10)65515-0","article-title":"Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features","volume":"155","author":"Bunone","year":"1999","journal-title":"Am J Pathol"},{"key":"key20180108015749_b31-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0959-8049(01)00015-6","article-title":"Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer","volume":"37","author":"Yonemura","year":"2001","journal-title":"Eur J Cancer"},{"key":"key20180108015749_b32-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/1566524011313040007","article-title":"NFAT gene family in inflammation and cancer","volume":"13","author":"Pan","year":"2013","journal-title":"Curr Mol Med"},{"key":"key20180108015749_b33-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"32521","DOI":"10.1074\/jbc.272.51.32521","article-title":"The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells","volume":"272","author":"Kroll","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180108015749_b34-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/sj.onc.1201380","article-title":"p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells","volume":"15","author":"Rousseau","year":"1997","journal-title":"Oncogene"},{"key":"key20180108015749_b35-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","article-title":"Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/Akt signal transduction pathway. Requirement for Flk-1\/KDR activation","volume":"273","author":"Gerber","year":"1998","journal-title":"J Biol Chem"},{"key":"key20180108015749_b36-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/sj.onc.1202527","article-title":"VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells","volume":"18","author":"Takahashi","year":"1999","journal-title":"Oncogene"},{"key":"key20180108015749_b37-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1101\/gad.14.13.1595","article-title":"A conserved family of calcineurin regulators","volume":"14","author":"Kingsbury","year":"2000","journal-title":"Genes Dev"},{"key":"key20180108015749_b38-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.0503846102","article-title":"Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo","volume":"102","author":"Chan","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108015749_b39-mmr-15-01-0263","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/EC.00336-08","article-title":"Aspergillus fumigatus calcipressin CbpA is involved in hyphal growth and calcium homeostasis","volume":"8","author":"Pinchai","year":"2009","journal-title":"Eukaryot Cell"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2016.5989\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T10:52:12Z","timestamp":1657968732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.5989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,6]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/mmr.2016.5989"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.5989","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,6]]}}}